Recognizable phenotypes in CDG
- PMID: 29654385
- PMCID: PMC5960425
- DOI: 10.1007/s10545-018-0156-5
Recognizable phenotypes in CDG
Abstract
Pattern recognition, using a group of characteristic, or discriminating features, is a powerful tool in metabolic diagnostic. A classic example of this approach is used in biochemical analysis of urine organic acid analysis, where the reporting depends more on the correlation of pertinent positive and negative findings, rather than on the absolute values of specific markers. Similar uses of pattern recognition in the field of biochemical genetics include the interpretation of data obtained by metabolomics, like glycomics, where a recognizable pattern or the presence of a specific glycan sub-fraction can lead to the direct diagnosis of certain types of congenital disorders of glycosylation. Another indispensable tool is the use of clinical pattern recognition-or syndromology-relying on careful phenotyping. While genomics might uncover variants not essential in the final clinical expression of disease, and metabolomics could point to a mixture of primary but also secondary changes in biochemical pathways, phenomics describes the clinically relevant manifestations and the full expression of the disease. In the current review we apply phenomics to the field of congenital disorders of glycosylation, focusing on recognizable differentiating findings in glycosylation disorders, characteristic dysmorphic features and malformations in PMM2-CDG, and overlapping patterns among the currently known glycosylation disorders based on their pathophysiological basis.
Conflict of interest statement
Conflicts of interest
Carlos R. Ferreira, Ruqaiah Altassan, Rita Francesco, Dorinda Marquez-Da-Silva, Jaak Jaeken and Eva Morava declare that they have no conflict of interest.
Figures


References
-
- Al Teneiji A, Bruun TUJ, Sidky S, et al. Phenotypic and genotypic spectrum of congenital disorders of glycosylation type I and type II. Mol Genet Metab. 2017;120:235–242. - PubMed
-
- Al-Maawali AA, Miller E, Schulze A, et al. Subcutaneous fat pads on body MRI–an early sign of congenital disorder of glycosylation PMM2-CDG (CDG1a) Pediatr Radiol. 2014;44:222–225. - PubMed
-
- Antoun H, Villeneuve N, Gelot A, et al. Cerebellar atrophy: an important feature of carbohydrate deficient glycoprotein syndrome type 1. Pediatr Radiol. 1999;29:194–198. - PubMed
-
- Artigas J, Cardo E, Pineda M, et al. Phosphomannomutase deficiency and normal pubertal development. J Inherit Metab Dis. 1998;21:78–79. - PubMed
-
- Barone R, Carrozzi M, Parini R, et al. A nationwide survey of PMM2-CDG in Italy: high frequency of a mild neurological variant associated with the L32R mutation. J Neurol. 2015;262:154–164. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources